Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: August 2011

4 - Epilepsy beginning in adolescence

References

1. Camfield C, Camfield PR, Gordon K, et al. Incidence of epilepsy in childhood and adolescence: a population based study in Nova Scotia form 1977–1985. Epilepsia 1996; 37: 19–23.
2. Svalheim S, Taubøll E, Bjørnenak T, et al. Onset of epilepsy and menarche – is there any relationship? Seizure 2006; 15: 571–5.
3. Diamantopoulos N, Crumrine PK. The effect of puberty on the course of epilepsy. Arch Neurol 1986; 43: 873–6.
4. Stephenson JB. Fits and Faints. Philadelphia PA, MacKeith Press 1990.
5. Appleton RE. Psychogenic non-epileptic seizures. Pediatric Epilepsy Current Awareness Service 2006; 1: 9–13.
6. Delagado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984; 34: 285–94.
7. Wirrell EC, Camfield CS, Camfield PR, Gordon K, Dooley J. Long-term prognosis of typical childhood absence epilepsy. Neurology 1996; 47: 912–18.
8. Hirtz D, Berg A, Bettis D, et al. Practice parameter: The evaluation of a first nonfebrile seizure in children (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 616–23.
9. Marson AG, Al-Kharusi, Alwaidh M, et al. SANAD Study Group. The SANAD study of effectiveness of valproate, lamotrigine or topiramate for treatment of generalized or unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 2007; 369: 1016–26.
10. Nicolson A, Marson AG. When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy. Pract Neurol 2010; 10: 208–18.
11. Loddenkemper T, Benbadis SR, Serrasota JM, Berkovic SF. Idiopathic generalized epilepsy syndromes of childhood and adolescence. In: Wyllie E, ed. The Treatment of Epilepsy Principles and Practice. Philadelphia, PA, Lippincott Williams and Wilkins 2006; p. 296.
12. Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009; 73: 1041–5.
13. Alving J, Beniczky S. Diagnostic usefulness and duration of the inpatient long-term video−EEG monitoring: findings in patients extensively investigated before the monitoring. Seizure 2010; 18: 470–3.
14. National Institute for Health and Clinical Excellence (NICE). The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical Guideline 20. NICE October 2004; www.nice.org.uk.
15. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of epilepsies in children and young people Guideline 81. SIGN March 2005; www.sign.ac.uk.
16. Hirtz D, Berg A, Bettis D, et al. Practice parameter: treatment of the child with a first unprovoked seizure. Report of the Quality Standards Subcommittee of the American Academy of Neurology and Practice Committee of the Child Neurology Society. Neurology 2003; 60: 166–75.
17. Canadian Study Group for Childhood Epilepsy. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998; 39: 850–6.
18. Wheless JW and the EPMN-105 Study Group. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol 2004; 19: 135–41.
19. Marson AG, Al-Kharusi, Alwaidh M, et al. SANAD Study Group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000–15.
20. Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: meta-analysis. Neurology 1994; 44: 601–8.
21. Dooley JM, Gordon K, Camfield PR, et al. Discontinuation of anticonvulsant therapy in children free of seizures for 1 year. Neurology 1996; 46: 969–74.
22. Peters AC, Brouwer OF, Geerts AT, et al. Randomized prospective study of early discontinuation of AEDs in children with epilepsy. Neurology 1998; 50: 724–30.
23. Braathen G, Anderson T, Gylie H, et al. A comparison between one and three years of treatment in uncomplicated childhood epilepsy: a prospective study. 1. Outcome in different seizure types. Epilepsia 1996; 37: 822–32.
24. Ranganathian LN, Ramaratnam S. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database Syst Rev 2006; 19: CD005003.
25. Tennison M, Greenwood R, Lewis D, Thorn M. Discontinuing antiepileptic drugs in children with epilepsy: a comparison of a six-week and a nine-month taper. N Engl J Med 1994; 330: 1407–10.
26. Appleton RE. Epilepsy in the teenager. Paediatr Child Health 2009; 19: 232–5.
27. Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): II teratogenesis and perinatal outcomes. Epilepsia 2009; 50: 1237–46.
28. Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): III vitamin K, folic acid, blood levels, and breast feeding. Epilepsia 2009; 50: 1247–55.
29. Tudur -Smith C, Marson AG, Chadwick DW, Williamson PR. Multiple treatment comparisons in epilepsy monotherapy trials. Trials 2007; 8: 34.
30. Kwan P, Brodie M. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314–19.
31. Aldenkamp AP, Weber B, Overweg-Plandsoen WCG, Reijs R, van Mil S. Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement. J Child Neurol 2005; 20: 175–80.
32. Appleton RE, Chadwick D, Sweeney A. Managing the teenager with epilepsy: pediatric to adult care. Seizure 1997; 6: 27–30.